AI boosts cataract surgery precision for severely nearsighted patients

NCT ID NCT06616506

Recruiting now Diagnosis Sponsor: Shanghai High Myopia Study Group Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will enroll 500,000 people with high myopia and cataracts to develop an artificial intelligence model that helps doctors calculate the correct lens power and grade cataracts more accurately. The goal is to improve vision outcomes and reduce complications after surgery. Participants must have an axial length of 26 mm or more and complete at least one month of follow-up after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract degenerative myopia disease myopia myopia, high, with cataract and vitreoretinal degeneration Risk Reduction Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTOMATIC JUDGEMENT CATARACT DIAGNOSES DISEASE HIGH MYOPIA MYOPIA RISK REDUCTION

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Eye and ENT Hospital of Fudan University
RECRUITING

Shanghai, Shanghai Municipality, 200031, China

Contact Phone: •••-•••-•••• Email: •••••@•••••